A carregar...

Serum biomarkers confirming stable remission in inflammatory bowel disease

Crohn's disease (CD) and ulcerative colitis (UC) have a chronic-remittent course. Optimal management of inflammatory bowel diseases (IBD) relies on early intervention, treat-to-target strategies and a tight disease control. However, it is challenging to assess the risk of relapses in individual...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Kessel, Christoph, Lavric, Miha, Weinhage, Toni, Brueckner, Markus, de Roock, Sytze, Däbritz, Jan, Weber, Jakob, Vastert, Sebastiaan J., Foell, Dirk
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7988138/
https://ncbi.nlm.nih.gov/pubmed/33758351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86251-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!